The transformation of brain implantsNicolas Vachicouras, CEO of Neurosoft Bioelectronics, tells us how Neurosoft’s electrode implant aims to reduce inflammation and scar Share XThe transformation of brain implantshttps://pharmaphorum.com/r-d/the-transformation-of-brain-implants/
The power of R&D collaborations to improve outcomes in rare diseasesFar more common than initially thought, rare disease treatments remain far too scarce. The answer to the problem, Share XThe power of R&D collaborations to improve outcomes in rare diseaseshttps://pharmaphorum.com/webinars/pharma-research-outcomes-rare-diseases/
Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcastEpisode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply Share XNovartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/novartis-amit-nastik-pharma-supply-chain/
Treatment for all: the key steps to better representation in pharmaAs people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says Share XTreatment for all: the key steps to better representation in pharmahttps://pharmaphorum.com/r-d/diversity-representation-pharma-clinical-trials/
Early detection of cancers will require blood sweat and tearsAn NHS study of a new cancer blood test holds huge promise, but will not be without its Share XEarly detection of cancers will require blood sweat and tearshttps://pharmaphorum.com/r-d/galleri-test-nhs-early-detection-cancers/
France’s biotech ecosystem is primed for growth – it’s time to feed itAfter some years of stagnant funding and growth France is now at an inflection point for health care Share XFrance’s biotech ecosystem is primed for growth – it’s time to feed ithttps://pharmaphorum.com/r-d/france-biotech-ecosystem-jeito-capital/
Biotech Insight podcast: Overcoming planning challenges in oncologyThe first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges Share XBiotech Insight podcast: Overcoming planning challenges in oncologyhttps://pharmaphorum.com/podcast/biotech-insight-oncology-planning/
Targeting COVID-19 and cancer with immunotherapy advancementsAnna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform. Over the last 30 years, we Share XTargeting COVID-19 and cancer with immunotherapy advancementshttps://pharmaphorum.com/r-d/targeting-covid-19-cancer-immunotherapy-advancements/
External control arms and debunking real-world data mythsFor the healthcare ecosystem to drive research and care, clarity is needed about the opportunities and challenges of Share XExternal control arms and debunking real-world data mythshttps://pharmaphorum.com/r-d/external-control-arms-real-world-data/
